Geode Capital Management LLC lifted its position in Heska Corp (NASDAQ:HSKA) by 31.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 92,734 shares of the medical research company’s stock after buying an additional 22,378 shares during the quarter. Geode Capital Management LLC owned approximately 1.22% of Heska worth $7,984,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. Dimensional Fund Advisors LP lifted its position in Heska by 0.6% during the 4th quarter. Dimensional Fund Advisors LP now owns 219,430 shares of the medical research company’s stock worth $18,893,000 after acquiring an additional 1,253 shares during the period. Bessemer Group Inc. purchased a new position in shares of Heska during the 4th quarter worth approximately $362,000. Great West Life Assurance Co. Can raised its stake in shares of Heska by 14.0% during the 4th quarter. Great West Life Assurance Co. Can now owns 9,581 shares of the medical research company’s stock worth $759,000 after buying an additional 1,174 shares in the last quarter. AlphaOne Investment Services LLC purchased a new position in shares of Heska during the 4th quarter worth approximately $2,092,000. Finally, Martingale Asset Management L P purchased a new position in shares of Heska during the 4th quarter worth approximately $1,155,000. Hedge funds and other institutional investors own 84.15% of the company’s stock.
In related news, COO Jason A. Napolitano sold 7,500 shares of the firm’s stock in a transaction that occurred on Monday, February 4th. The stock was sold at an average price of $100.00, for a total value of $750,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders sold a total of 22,500 shares of company stock valued at $2,199,825 over the last ninety days. 14.00% of the stock is currently owned by company insiders.
A number of equities analysts have recently issued reports on the company. BidaskClub downgraded Heska from a “hold” rating to a “sell” rating in a research note on Friday, April 5th. Zacks Investment Research downgraded Heska from a “buy” rating to a “strong sell” rating in a research note on Tuesday, March 5th. B. Riley cut their target price on Heska from $93.00 to $87.00 and set a “neutral” rating for the company in a research note on Wednesday, February 27th. Benchmark downgraded Heska from a “buy” rating to a “hold” rating in a research note on Wednesday, February 27th. Finally, Sidoti downgraded Heska from a “buy” rating to a “neutral” rating in a research note on Tuesday, February 26th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $109.00.
Shares of HSKA stock opened at $74.66 on Wednesday. The company has a market cap of $587.48 million, a PE ratio of 52.58 and a beta of 0.80. Heska Corp has a 12-month low of $71.60 and a 12-month high of $114.50.
Heska (NASDAQ:HSKA) last issued its earnings results on Tuesday, February 26th. The medical research company reported $0.46 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.75 by ($0.29). The business had revenue of $34.06 million for the quarter, compared to analysts’ expectations of $40.59 million. Heska had a return on equity of 9.87% and a net margin of 4.59%.
TRADEMARK VIOLATION WARNING: “Heska Corp (HSKA) Shares Bought by Geode Capital Management LLC” was first posted by Macon Daily and is the property of of Macon Daily. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://macondaily.com/2019/04/17/heska-corp-hska-shares-bought-by-geode-capital-management-llc.html.
Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The company's Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; COAG veterinary analyzers; Element i immunodiagnostic analyzers; and IV infusion pumps.
Recommended Story: What factors cause inflation to rise?
Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.